Five Prime Therapeutics

Secondary offerings by small biotech companies have brought out the insider buyers recently, as did the sell-off following Microsoft's disappointing quarterly report. Insiders may sell shares for any number of reasons, but conventional wisdom says that they really only buy shares of a company for...

U.S. stocks rose as investors focused on positive economic data rather than the tense situation in Ukraine. Economic reports showed that U.S. industrial production rose in February. President Obama imposed sanctions against Russian and Crimea officials following an election on Sunday which...